Загрузка...
Sclerostin Inhibition in the Management of Osteoporosis
The recognition of the importance of the Wnt-signaling pathway in bone metabolism and studies of patients with rare skeletal disorders characterized by high bone mass identified sclerostin as target for the development of new therapeutics for osteoporosis. Findings in animals and humans with scleros...
Сохранить в:
| Опубликовано в: : | Calcif Tissue Int |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824823/ https://ncbi.nlm.nih.gov/pubmed/27016922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-016-0126-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|